Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European Journal of Neuroscience

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/J.1460-9568.2003.02469.XPMID 12581184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Striatal expression of FosB-related transcription factors in human Parkinson's disease: Relation to L-dopa-induced dyskinesia

  2002cited by this paper
• L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.

  2002cited by this paper
• cAMP Response Element-Binding Protein Is Required for Dopamine-Dependent Gene Expression in the Intact But Not the Dopamine-Denervated Striatum

  2001influential reference
• Regulation of mRNA stability in the nervous system and beyond

  2001cited by this paper
• Persistent changes in striatal gene expression induced by long‐term l‐DOPA treatment in a rat model of Parkinson's disease

  2001cited by this paper
• Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis.

  2000cited by this paper
• The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson’s disease

  2000cited by this paper
• Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment.

  1999influential reference
• Compartmental changes in expression of c-Fos and FosB proteins in intact and dopamine-depleted striatum after chronic apomorphine treatment.

  1999cited by this paper
• Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease.

  1999influential reference
• CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.

  1999cited by this paper
• D1-Receptor-related priming is attenuated by antisense-meditated 'knockdown' of fosB expression.

  1998cited by this paper
• L‐DOPA‐induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin‐ and glutamic acid decarboxylase mRNA

  1998influential reference
• FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects.

  1997cited by this paper
• Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins.

  1997cited by this paper
• Chronic Fos-Related Antigens: Stable Variants of ΔFosB Induced in Brain by Chronic Treatments

  1997cited by this paper
• Chronic Alterations in Dopaminergic Neurotransmission Produce a Persistent Elevation of ΔFosB‐like Protein(s) in both the Rodent and Primate Striatum

  1996cited by this paper
• Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal.

  1996cited by this paper
• Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments.

  1994influential reference
• Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum

  1993cited by this paper
• Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine.

  1992cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983influential reference
• Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.

  1973cited by this paper

• Voluntary Running and Estrous Cycle Modulate ΔFOSB in the Suprachiasmatic Nucleus of the Wistar Rat

  2025cites this paper
• Serotonin-dopamine interactions in psychostimulant-induced gene regulation: SSRI antidepressants potentiate gene regulation by methylphenidate (Ritalin) in the striatum and enhance behavioral profile indicative of addiction liability in rodents.

  2025cites this paper
• Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis

  2024cites this paper
• Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression.

  2023cites this paper
• ΔFOSB: A Potentially Druggable Master Orchestrator of Activity-Dependent Gene Expression.

  2022cites this paper
• Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L‐Dopa‐induced dyskinesia in parkinsonian rats

  2020cites this paper
• Knock-Down of GPR88 in the Dorsal Striatum Alters the Response of Medium Spiny Neurons to the Loss of Dopamine Input and L-3-4-Dyhydroxyphenylalanine

  2019cites this paper
• Reward Network Immediate Early Gene Expression in Mood Disorders

  2017cites this paper
• The effect of L-dopa and neuroprotective agents on cell replacement therapy for Parkinson's disease

  2017cites this paper
• Antidyskinetic Effects of MEK Inhibitor Are Associated with Multiple Neurochemical Alterations in the Striatum of Hemiparkinsonian Rats

  2017cites this paper
• Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?

  2016cites this paper
• Chronic Stress Is Associated with Pain Precipitation and Elevation in DeltaFosb Expression

  2016cites this paper
• Accumulation of Highly Stable ÃÂFosB-Isoforms and Its Targets inside theReward System of Chronic Drug Abusers - A Source of Dependence-Memoryand High Relapse Rate?

  2016cites this paper
• Role of hippocampal activity-induced transcription in memory consolidation

  2016cites this paper
• Gene Expression Analyses Identify Narp Contribution in the Development of l-DOPA-Induced Dyskinesia

  2015cites this paper
• Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.

  2015cites this paper
• RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.

  2014cites this paper
• L-DOPA-induced signaling pathways and neuroepigenetic mechanisms in experimental Parkinsonism and dyskinesia

  2014cites this paper
• Molecular neurobiology of addiction: what’s all the (Δ)FosB about?

  2014cites this paper
• Les enképhalines et dynorphines dans la résilience au stress chronique

  2013cites this paper
• Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.

  2013cites this paper
• Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia.

  2012cites this paper
• Small molecule screening identifies regulators of the transcription factor ΔFosB.

  2012cites this paper
• Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

  2011cites this paper
• Interaction of Transient Receptor Potential Vanilloid 1 (TRPV1) with G-protein coupled receptors and TRP ion channels

  2011cites this paper
• Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway.

  2011cites this paper
• Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.

  2010cites this paper
• Enhanced striatal cholinergic neuronal activity mediates l-DOPA–induced dyskinesia in parkinsonian mice

  2010cites this paper
• Striatal Overexpression of ΔFosB Reproduces Chronic Levodopa-Induced Involuntary Movements

  2010cites this paper
• Handbook of basal ganglia structure and function

  2010cites this paper
• Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease.

  2009cites this paper
• Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats

  2009cites this paper
• Overexpression of DeltaFosB is associated with attenuated cocaine-induced suppression of saccharin intake in mice.

  2009cites this paper
• Contribution of the striatum to the effects of 5‐HT1A receptor stimulation in L‐DOPA‐treated hemiparkinsonian rats

  2009cites this paper
• Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats

  2009cites this paper
• Pharmacological Modulation of Glutamate Transmission in a Rat Model of l-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling

  2009cites this paper
• Intermittent L-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats.

  2008cites this paper
• Long‐lasting alteration in mesocorticolimbic structures after repeated social defeat stress in rats: time course of µ‐opioid receptor mRNA and FosB/ΔFosB immunoreactivity

  2008cites this paper
• Dopamine Dysregulation Syndrome and Levodopa-Induced Dyskinesias in Parkinson Disease: Common Consequences of Anomalous Forms of Neural Plasticity

  2008cites this paper
• Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease.

  2008cites this paper
• Role of fosB in behaviours related to morphine reward and spatial memory.

  2008cites this paper
• Antagonism of metabotropic glutamate receptor type 5 attenuates l‐DOPA‐induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson’s disease

  2007cites this paper
• Regulation of ΔFosB transcriptional activity by Ser27 phosphorylation

  2007cites this paper
• Expression pattern of JunD after acute or chronic L-DOPA treatment: comparison with deltaFosB.

  2007cites this paper
• Canadian Association of Neurosciences Review: The Role of Dopamine Receptor Function in Neurodegenerative Diseases

  2007cites this paper
• Changes in the prodynorphin gene and DARPP-32 state in 6-OHDA-lesioned rats following long-term treatment with l-dopa.

  2007cites this paper
• Dimerization and DNA-binding properties of the transcription factor DeltaFosB.

  2007cites this paper
• Elevations of FosB in the nucleus accumbens during forced cocaine abstinence correlate with divergent changes in reward function.

  2007cites this paper
• Concomitant short‐ and long‐duration response to levodopa in the 6‐OHDA‐lesioned rat: a behavioural and molecular study

  2007cites this paper
• Advances in understanding L-DOPA-induced dyskinesia.

  2007cites this paper
• Regulation of fosB and DeltafosB mRNA expression: in vivo and in vitro studies.

  2007cites this paper
• Pleiotropic impact of constitutive fosB inactivation on nicotine-induced behavioral alterations and stress-related traits in mice.

  2007cites this paper
• High-Frequency Stimulation of the Subthalamic Nucleus Potentiates l-DOPA-Induced Neurochemical Changes in the Striatum in a Rat Model of Parkinson's Disease

  2007cites this paper
• Proteasome‐dependent and ‐independent mechanisms for FosB destabilization: identification of FosB degron domains and implications for ΔFosB stability

  2007influential citation
• L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.

  2007cites this paper
• Effect of antisense FosB and CREB on the expression of prodynorphin gene in rats with Levodopa-induced dyskinesias

  2006cites this paper
• Rôle et régulation du récepteur D1 de la dopamine dans le striatum : implications dans les dyskinésies de la maladie de Parkinson

  2006cites this paper
• Post‐ versus presynaptic plasticity in L‐DOPA‐induced dyskinesia

  2006cites this paper
• The transcription factor DeltaFosB is recruited by inflammatory pain.

  2006cites this paper
• Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.

  2006cites this paper
• Perinatal protein malnutrition enhances rewarding cocaine properties in adult rats.

  2006cites this paper
• Regulation of DeltaFosB stability by phosphorylation.

  2006cites this paper
• Parkinson’s Disease, the Dopamine System and Immediate Early Genes

  2006cites this paper
• The transcription factor ΔFosB is recruited by inflammatory pain

  2006cites this paper
• Reversion of levodopa‐induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6‐OHDA‐lesioned rats

  2006cites this paper
• [Role and regulation of dopamine D1 receptors in the striatum: implications for the genesis of dyskinesia in Parkinson's disease].

  2006cites this paper
• New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity.

  2005cites this paper
• ΔFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment

  2005cites this paper
• Psychostimulant withdrawal as an inducing condition in animal models of depression.

  2005cites this paper
• Increased extracellular dopamine concentrations and FosB/ΔFosB expression in striatal brain areas of heterozygous GDNF knockout mice

  2004cites this paper
• A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.

  2004cites this paper
• [Hypothesis: Parkinson's disease, reward deficiency syndrome and addictive effects of levodopa].

  2004cites this paper
• DeltaFosB: a molecular switch for long-term adaptation in the brain.

  2004cites this paper
• Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation

  2003cites this paper
• Molecular Neurobiology of Drug Addiction

  1994cites this paper